The role of hypoxia-inducible factor-2 in digestive system cancersJun Zhao, Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College)Cell Death and DiseaseJanuary 15, 201510.1038/cddis.2014.565Cited by 124SaveCiteExport RISWatch citationsRelated PapersCustomizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021|Annals of Oncology|2021|792Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone|Breast Cancer Research|2014|31PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer|Cell Death and Disease|2023|11